PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Form 10-Q Quarterly Reports
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PVCT
CIK: 315545
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerAngelica Kocharova
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-10 | 4 | 0001493152-26-046701 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-03 | 4 | 0001493152-26-045713 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-18 | 4 | 0001493152-26-043276 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-11 | 4 | 0001493152-26-042331 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001493152-26-041727 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-26 | 4 | 0001493152-26-040207 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037671 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-22 | — | SCHEDULE 13D/A Filing | 0001493152-26-034217 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001493152-26-031718 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-30 | 8-K | 0001493152-26-031379 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-30 | 4 | 0001493152-26-031404 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-30 | 4 | 0001493152-26-031403 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-30 | 4 | 0001493152-26-031402 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001493152-26-029512 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | 8-K | 0001493152-26-029280 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-05 | 4 | 0001493152-26-027467 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 | 0001493152-26-026269 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-23 | 4 | 0001493152-26-025188 | View SEC Doc Filr Page |
| 4 | 2026-05-15 | 2026-05-15 | 4 | 0001493152-26-023486 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-022950 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-05-07 | 4 | 0001493152-26-021663 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001493152-26-019810 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001493152-26-019807 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001493152-26-019805 | View SEC Doc Filr Page |
| 4 | 2026-04-29 | 2026-04-29 | 4 | 0001493152-26-019644 | View SEC Doc Filr Page |